This segment focuses on the research, development, and commercialization of novel oncology therapies. Spectrum Pharmaceuticals is actively involved in the discovery and development of innovative drugs targeting various types of cancer. Research and development activities include preclinical studies, clinical trials, and regulatory submissions. The company utilizes advanced technologies and methodologies in drug discovery, including targeted therapies and antibody-drug conjugates. The primary therapeutic areas are hematology and oncology, with a focus on improving patient outcomes and addressing unmet medical needs. Market positioning is based on providing innovative cancer treatments. Future opportunities include expanding the product pipeline and entering new markets. This segment involves partnerships with other pharmaceutical companies and collaborations with research institutions.

This segment encompasses the commercialization and marketing of Spectrum Pharmaceuticals' approved drug products. It involves sales, marketing, and distribution activities across various geographic regions. The company's commercial operations are focused on ensuring patient access to its oncology and hematology drugs. This includes building relationships with healthcare providers, managing supply chains, and providing patient support services. The segment leverages market research, data analytics, and digital marketing strategies to reach target audiences. The primary therapeutic areas are oncology and hematology. The company aims to improve patient outcomes by providing access to effective treatments. Market positioning is based on providing innovative cancer treatments. Future opportunities include expanding the commercial footprint and launching new products. This segment involves partnerships with distributors and collaborations with patient advocacy groups.

This segment is dedicated to the discovery, development, and clinical testing of novel drug candidates, primarily in the field of oncology and hematology. The R&D activities include preclinical research, clinical trials (Phases 1-3), and regulatory submissions. Spectrum Pharmaceuticals utilizes advanced technologies such as targeted therapies, tyrosine kinase inhibitors, and antibody-drug conjugates. The therapeutic focus is on treating various cancers and hematological disorders, aiming to improve patient survival and quality of life. The company's market positioning is based on its pipeline of innovative drug candidates. Future opportunities include expanding the pipeline, securing regulatory approvals, and entering new markets. This segment involves collaborations with research institutions, co-development agreements with other pharmaceutical companies, and in-licensing of promising drug candidates.